Quarterly report pursuant to Section 13 or 15(d)

LOSS PER SHARE

v3.21.2
LOSS PER SHARE
9 Months Ended
Sep. 30, 2021
LOSS PER SHARE  
LOSS PER SHARE

6. LOSS PER SHARE

The following table sets forth the computation of basic and fully diluted loss per share for the three and months ended September 30, 2021 and 2020 (stated in thousands, except per share amounts):

    

Three Months Ended September 30,

Nine Months Ended September 30, 

2021

    

2020

2021

    

2020

Net income (loss)

$

91

$

(977)

$

(2,447)

$

(14,711)

Basic weighted average common stock outstanding

 

11,838,032

 

6,988,058

 

11,528,371

 

6,968,728

Basic income (loss) per share

$

0.01

$

(0.14)

$

(0.21)

$

(2.11)

Net income (loss)

$

91

$

(977)

$

(2,447)

$

(14,711)

Basic weighted average common shares outstanding

 

11,838,032

 

6,988,058

 

11,528,371

 

6,968,728

Dilutive effect of stock options and warrants

 

3,886,071

 

 

 

Dilutive weighted average common stock outstanding

 

15,724,103

 

6,988,058

 

11,528,371

 

6,968,728

Diluted income (loss) per share

$

0.01

$

(0.14)

$

(0.21)

$

(2.11)

Basic net income (loss) per share is computed using the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed using the treasury stock method to calculate the weighted average number of shares of common stock and, if dilutive, potential shares of common stock outstanding during the period. Potential dilutive shares of common stock include incremental shares of common stock issuable upon the exercise of stock options, less shares from assumed

proceeds. The assumed proceeds calculation includes actual proceeds to be received from the employee upon exercise and the average unrecognized stock compensation cost during the period.

Stock options, exercisable, to purchase 227,893 shares of common stock and warrants to purchase 462,068 shares of common stock were outstanding at September 30, 2021 that were not included in the computation of diluted weighted average common stock outstanding because their effect would have been anti-dilutive.